
Please try another search
Pre-Open Stock Movers:
Spectrum Pharmaceuticals , Inc. (Nasdaq: NASDAQ:SPPI) 18% HIGHER; announced data from a poster presentation titled: High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer (NSCLC). The data show that poziotinib is highly active in G778 mutations in both treatment naïve and previously treated patients with NSCLC.
Carvana (CVNA) 8% HIGHER; Piper Sandler upgraded from Neutral to Overweight with a price target of $73.00 (from $98.00).
Bristol-Myers Squibb (NYSE:BMY) 7% HIGHER; U.S. FDA approved Deucravacitinib, now known as Sotyktu, for the treatment of psoriasis.
Relay Therapeutics, Inc. (Nasdaq: RLAY) 5% LOWER; commenced an underwritten public offering of $300.0 million of shares of its common stock. Relay Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering. All of the shares in the proposed offering are to be sold by Relay Therapeutics.
Bill.com Holdings Inc. (NYSE:BILL) 3% HIGHER; Morgan Stanley initiates coverage with an Overweight rating and a price target of $220.00.
Apache Corp . (NASDAQ:APA) 3% HIGHER; Citi upgraded from Neutral to Buy with a price target of $58.00 (from $40.00).
Union Pacific (NYSE:UNP) 2% HIGHER; BofA Securities upgraded from Neutral to Buy with a price target of $260.00.
Adobe (NASDAQ:ADBE) 2% LOWER; Mizuho Securities downgraded from Buy to Neutral with a price target of $440.00 (from $480.00).
Roblox Corp. (RBLX) 2% LOWER; Cowen initiates coverage with an Underperform rating and a price target of $31.00.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.